Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

fludarabine oral

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Generic mfg.

Drug class:

DNA synthesis inhibitor

Related drugs:

‹

captisol-enabled melphalan (0)

cisplatin (330)

gemcitabine (181)

temozolomide (114)

cytarabine (99)

oxaliplatin (57)

dacarbazine (22)

cytarabine/daunorubicin liposomal formulation (19)

clofarabine (16)

carmustine (14)

temozolomide gel (7)

fludarabine IV (6)

hydroxyurea (3)

mercaptopurine (3)

fotemustine (2)

streptozocin (2)

thioguanine (2)

fosgemcitabine palabenamide (1)

asparagine cytarabine conjugate (1)

gemcitabine-releasing intravesical system (1)

mitomycin urothelial gel (1)

melphalan hepatic delivery system (1)

liposomal cisplatin (0)

pegylated liposomal mitomycin-c prodrug (0)

mercaptopurine oral suspension (0)

gemcitabine with RenovoCath (0)

cytarabine ocfosfate (0)

mitomycin intravesicular (0)

captisol-enabled melphalan (0)

›

No biomarker	Waldenstrom Macroglobulinemia	No biomarker	Waldenstrom Macroglobulinemia	fludarabine oral Sensitive: A2 - Guideline fludarabine oral Sensitive : A2	fludarabine oral Sensitive: A2 - Guideline fludarabine oral Sensitive : A2
GZMA underexpression	Hepatocellular Cancer	GZMA underexpression	Hepatocellular Cancer	fludarabine oral Sensitive: D – Preclinical fludarabine oral Sensitive : D	fludarabine oral Sensitive: D – Preclinical fludarabine oral Sensitive : D